Researchers seek to understand the biology of sepsis in neutropenic patients

by Lee-Ann Donegan

(Medical Xpress)—Sepsis comes with serious consequences. The blood infection, most commonly caused by bacteria, can lead to septic shock, organ failure, loss of limbs, and even death. Patients whose immune systems are already compromised are at even greater risk.

Nuala J. Meyer, MD, an assistant professor of Pulmonary, Allergy and Critical Care in the Perelman School of Medicine at the University of Pennsylvania examined the effects of sepsis on neutropenic . She will present her findings in the poster discussion session at the American Thoracic Society meeting, Monday, May 19, in San Diego.

Neutropenia, a condition in which patients have a low number of infection-fighting , can occur as a result of anemia, certain cancers or chemotherapy treatment, and other hereditary disorders.

Meyer looked at a single-center cohort of patients who presented to the emergency department or medical ICU with . Of the 1,269 patients studied, nine percent were neutropenic; 75 percent had hematalogic malignancy; 15 percent had metastatic solid organ malignancy, and 15 percent were . Neutropenic patients had a higher incidence of shock and were more likely to die within 60 days, a retrospective review of their electronic health record found. Meyer and her team set out to understand why this occurs.

"We hypothesized that the neutropenic patients would have higher levels of the growth factor angiopoietin 2, a vascular growth factor and marker of injured vessels, and that these would serve as biomarkers for the most severe cases of neutropenic sepsis," says Meyer. Increased levels of angiopoietin is known to lead to an increase of permeability of the blood vessel, which allows the contaminated blood to travel more easily from the vessel to the rest of the body and vice versa.

Contrary to this, the study showed that the neutropenic patients not only had lower than expected levels of angiopoietin 2, but they also had high levels of inflammatory cytokines, specifically interleukin-8, a protein important to the body's immune response. "The neutropenic patients, despite a low white blood cell count, surprised us with the increased number of cytokines compared to the immunocompetant patients," Meyer said.

This led the team to believe that mortality risk for sepsis patients might be associated with high cytokine levels independent of severity of illness, and that anti-inflammatory medications targeting interleukin-8 specifically, might be helpful, even among neutropenic patients, as interleukin-8 is highly associated with mortality. "In the future, testing for interleukin-8 in septic patients could lead to early intervention with inflammatory medication, and possibly, better outcomes for patients," says Meyer.

add to favorites email to friend print save as pdf

Related Stories

Sepsis involved in high percentage of hospital deaths

May 18, 2014

An analysis that included approximately 7 million hospitalizations finds that sepsis contributed to 1 in every 2 to 3 deaths, and most of these patients had sepsis at admission, according to a study published by JAMA. The st ...

Scientists bring to light mechanism of drug for infections

Nov 14, 2013

Scientists at A*STAR's Singapore Immunology Network (SIgN) have discovered the exact mode of action by plerixafor, a drug commonly prescribed to stimulate immune responses in patients suffering from neutropenia, which causes ...

Recommended for you

New hay fever blood test nothing to sneeze at

Sep 29, 2014

(Medical Xpress)—Brisbane researchers have developed a blood test that can accurately detect one of the commonest causes of hay fever, paving the way for new treatments.

Geisel researchers contribute to study of trained immunity

Sep 26, 2014

A study published in the journal science provides support for a new—and still controversial—understanding of the immune system. the research was conducted by collaborators in the U.S. and Europe, including Robert Cramer ...

User comments